448 related articles for article (PubMed ID: 28272220)
1. Clinical study of duloxetine hydrochloride combined with doxazosin for the treatment of pain disorder in chronic prostatitis/chronic pelvic pain syndrome: An observational study.
Zhang M; Li H; Ji Z; Dong D; Yan S
Medicine (Baltimore); 2017 Mar; 96(10):e6243. PubMed ID: 28272220
[TBL] [Abstract][Full Text] [Related]
2. Comparison of cernitin pollen extract vs tadalafil therapy for refractory chronic prostatitis/chronic pelvic pain syndrome: A randomized, prospective study.
Matsukawa Y; Naito Y; Funahashi Y; Ishida S; Fujita T; Tochigi K; Kato M; Gotoh M
Neurourol Urodyn; 2020 Sep; 39(7):1994-2002. PubMed ID: 32648985
[TBL] [Abstract][Full Text] [Related]
3. Treatment of refractory category III nonbacterial chronic prostatitis/chronic pelvic pain syndrome with intraprostatic injection of onabotulinumtoxinA: a prospective controlled study.
Abdel-Meguid TA; Mosli HA; Farsi H; Alsayyad A; Tayib A; Sait M; Abdelsalam A
Can J Urol; 2018 Apr; 25(2):9273-9280. PubMed ID: 29680006
[TBL] [Abstract][Full Text] [Related]
4. The efficacy and safety of duloxetine in a multidrug regimen for chronic prostatitis/chronic pelvic pain syndrome.
Giannantoni A; Porena M; Gubbiotti M; Maddonni S; Di Stasi SM
Urology; 2014 Feb; 83(2):400-5. PubMed ID: 24231216
[TBL] [Abstract][Full Text] [Related]
5. Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study.
Mehik A; Alas P; Nickel JC; Sarpola A; Helström PJ
Urology; 2003 Sep; 62(3):425-9. PubMed ID: 12946740
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of Persistent Somatoform Pain Disorder by Floating Needle Therapy and Duloxetine].
Ren WW; Zhou ZY; Xu MM; Long S; Tang GZ; Mao HJ; Chen SL
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Feb; 36(2):166-71. PubMed ID: 27078991
[TBL] [Abstract][Full Text] [Related]
7. Eviprostat has an identical effect compared to pollen extract (Cernilton) in patients with chronic prostatitis/chronic pelvic pain syndrome: a randomized, prospective study.
Iwamura H; Koie T; Soma O; Matsumoto T; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Ohyama C
BMC Urol; 2015 Dec; 15():120. PubMed ID: 26643109
[TBL] [Abstract][Full Text] [Related]
8. Effect of acupuncture on quality of life in patients with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial.
Wang H; Ji Y; Zhang S; Yuan P; Zhao H; Guo Y; Xie X; Ding Y
Zhongguo Zhen Jiu; 2024 Apr; 44(4):411-417. PubMed ID: 38621728
[TBL] [Abstract][Full Text] [Related]
9. Fluoxetine ameliorates symptoms of refractory chronic prostatitis/chronic pelvic pain syndrome.
Xia D; Wang P; Chen J; Wang S; Jiang H
Chin Med J (Engl); 2011 Jul; 124(14):2158-61. PubMed ID: 21933619
[TBL] [Abstract][Full Text] [Related]
10. Transurethral intraprostatic injection of botulinum neurotoxin type A for the treatment of chronic prostatitis/chronic pelvic pain syndrome: results of a prospective pilot double-blind and randomized placebo-controlled study.
Falahatkar S; Shahab E; Gholamjani Moghaddam K; Kazemnezhad E
BJU Int; 2015 Oct; 116(4):641-9. PubMed ID: 25307409
[TBL] [Abstract][Full Text] [Related]
11. Comparison of transcutaneous tibial nerve stimulation versus percutaneous tibial nerve stimulation in category IIIB chronic prostatitis/chronic pelvic pain syndrome: A randomized prospective trial.
Sevim M; Alkiş O; Kartal İG; Kazan HO; İvelik Hİ; Aras B; Kabay Ş
Prostate; 2023 Jun; 83(8):751-758. PubMed ID: 36871235
[TBL] [Abstract][Full Text] [Related]
12. Symptom Severity Following Rifaximin and the Probiotic VSL#3 in Patients with Chronic Pelvic Pain Syndrome (Due to Inflammatory Prostatitis) Plus Irritable Bowel Syndrome.
Vicari E; Salemi M; Sidoti G; Malaguarnera M; Castiglione R
Nutrients; 2017 Nov; 9(11):. PubMed ID: 29099760
[TBL] [Abstract][Full Text] [Related]
13. Effect of Essential Oil on Patients with Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Pilot Randomized Controlled Trial.
Ying J; Zhou MJ; Chen HY; Chen L; Zhang W; Ji J; Yu C; Zhang ZJ
Chin J Integr Med; 2019 Feb; 25(2):91-95. PubMed ID: 29948596
[TBL] [Abstract][Full Text] [Related]
14. α-blockers, antibiotics and anti-inflammatories have a role in the management of chronic prostatitis/chronic pelvic pain syndrome.
Thakkinstian A; Attia J; Anothaisintawee T; Nickel JC
BJU Int; 2012 Oct; 110(7):1014-22. PubMed ID: 22471591
[TBL] [Abstract][Full Text] [Related]
15. The role of anticholinergic therapy based on the upoint system in the treatment of chronic prostatitis.
Narter KF; Can U; Coşkun A; Sabuncu K; Tarhan F
Arch Ital Urol Androl; 2019 Mar; 91(1):16-21. PubMed ID: 30932424
[TBL] [Abstract][Full Text] [Related]
16. Effects of Electroacupuncture with Different Waveforms on Chronic Prostatitis/Chronic Pelvic Pain Syndromes: A Randomized Controlled Trial.
Li Z; Liu J; Liu P; Zhang Y; Han W
Contrast Media Mol Imaging; 2022; 2022():6866000. PubMed ID: 35935300
[TBL] [Abstract][Full Text] [Related]
17. The role of nutraceutical medications in men with non bacterial chronic prostatitis and chronic pelvic pain syndrome: A prospective non blinded study utilizing flower pollen extracts versus bioflavonoids.
Maurizi A; De Luca F; Zanghi A; Manzi E; Leonardo C; Guidotti M; Antonaccio FP; Olivieri V; De Dominicis C
Arch Ital Urol Androl; 2019 Jan; 90(4):260-264. PubMed ID: 30655636
[TBL] [Abstract][Full Text] [Related]
18. Pentosan polysulfate therapy for chronic nonbacterial prostatitis (chronic pelvic pain syndrome category IIIA): a prospective multicenter clinical trial.
Nickel JC; Johnston B; Downey J; Barkin J; Pommerville P; Gregoire M; Ramsey E
Urology; 2000 Sep; 56(3):413-7. PubMed ID: 10962305
[TBL] [Abstract][Full Text] [Related]
19. Erectile Dysfunction in Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Outcomes from a Multi-Center Study and Risk Factor Analysis in a Single Center.
Zhang Y; Zheng T; Tu X; Chen X; Wang Z; Chen S; Yang Q; Wan Z; Han D; Xiao H; Sun X; Deng C
PLoS One; 2016; 11(4):e0153054. PubMed ID: 27120096
[TBL] [Abstract][Full Text] [Related]
20. A placebo-controlled comparison of the efficiency of triple- and monotherapy in category III B chronic pelvic pain syndrome (CPPS).
Tuğcu V; Taşçi AI; Fazlioğlu A; Gürbüz G; Ozbek E; Sahin S; Kurtuluş F; Cek M
Eur Urol; 2007 Apr; 51(4):1113-7; discussion 1118. PubMed ID: 17084960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
